Thermo Fisher Scientific rose over 2.2%, collaborating with OpenAI to improve drug development efficiency

Zhitong
2025.10.16 14:41

Medical device manufacturer Thermo Fisher Scientific rose over 2.2%, reporting $539.55. In terms of news, Thermo Fisher Scientific is collaborating with OpenAI to help improve the speed and success rate of drug development. The company stated that it is embedding OpenAI APIs into areas such as product development, service delivery, and customer engagement

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer